Gurugram's Fortis Memorial Research Institute starts Sputnik V trial run for general public
By ANI | Updated: June 27, 2021 23:50 IST2021-06-27T23:40:15+5:302021-06-27T23:50:07+5:30
The Fortis Memorial Research Institute in Gurugram has started its pilot soft launch of the Russian COVID-19 vaccine 'Sputnik V' and the hospital has procured the vaccine stock directly from Dr Reddy's Laboratories.
Gurugram's Fortis Memorial Research Institute starts Sputnik V trial run for general public
#SputnikV is more efficient against the Delta variant of coronavirus, first detected in India than any other vaccine that published results on this strain so far-- the Gamaleya Center study submitted for publication in an international peer-reviewed journal," Sputnik V on Tuesday tweeted.
According to the recent last statement over the pilot phase for Sputnik V, Dr Reddy's laboratories said that they aim to reach 28 cities in total.
"Our pilot phase initiated on May 14 in Hyderabad has been scaled up to Vizag, Bengaluru, Mumbai, Kolkata, Delhi, Chennai, Miryalaguda, Vijayawada, Baddi, Kolhapur, Raipur, Chandigarh, Pune, Nagpur, Ranchi, Jaipur so far. By the end of this final leg of the pilot phase. We aim to reach 28 cities in total. We will continue to share updates related to Sputnik V," added Dr Reddy's laboratories.
( With inputs from ANI )
Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor
Open in app